Why does the next deadline matter when they already missed two deadlines and lied about it the second time.
Management here is either inept or corrupt. Best product in the world can't be saved by poor management.
I am in NC also and I feel like I could have written the original post above. Exactly my feelings. BOJA is about as big a no-brainer stock as there is. And like bet it all said, Wall Street analysts simply have no experience with this restaurant chain, and that's why the stock isn't $40+ right now.
I own 5k shares and want to buy more, it is already 25% of my trading account lol. But I love this stock. I am kind of hoping it tanks on Thursday because I will come in with a big bet if it does.
There was no tactic or conspiracy. The drug is marginal at best, and PBYI was priced as though it had a miracle drug.
The market is now trying to price in the real future performance of the drug. Previous pie in the sky predictions are wildly off the mark, mostly aided by misrepresentations of the drugs performance by the company.
I'm loaded up for earnings. Added 1000 at 24.72 earlier. Now hold 5k shares. Will add more next week if they continue to fade the stock. This stock has nowhere to go but up in the future. Rock solid financials and a great product. Can't understand why there's any negativity and why such low PT's but if it wasn't for the market sheep we couldn't make any money.
As low as you want to look, no one is offering any size. You're crazy to be buying at this level imo.
Short covering and scalpers are the only things holding this up.
My guess is this drug, if it's ever approved, will end up on one of those late night commercials you see, where they are giving you the toll free number to call if you ever took this drug, so you can claim your portion of the class action proceeds.
#$%$ looks like Sanderson got suckered by a dead cat bounce. Sorry. Sub 100 soon.
You're right, and it's emotion that's keeping this stock north of $100 when it should be trading under $50
Analysts are pounding the table because they are in total denial. The market has spoken and PBYI is down $130 from highs. The market hates this drug.
Best news there is having a sell rating from Cramer. Very happy.
I honestly wouldn't take a newly developed drug with such a small improvement in outcomes. If the drug had years of positive history in real world use, I might be more willing to deal with sitting on the toilet all day while taking it. In any event it's an awful disease and a terrible choice, one I pray I never have to make.